Efficacy and safety of NMDA receptor antagonists augmentation therapy for schizophrenia: an updated meta-analysis of randomized placebo-controlled trials.
Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan.
Yuki
Y
Matsuda
Taro
T
Kishi
Nakao
N
Iwata
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D006801:Humans; D008559:Memantine / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors*; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents; D016194:Receptors, N-Methyl-D-Aspartate; D008559:Memantine
Amantadine; Efficacy; Memantine; Meta-analysis; NMDA receptor antagonists; Tolerability